Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. (Q43720394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

W D Flitter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W A Garland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G C Su

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G W Arendash

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

349-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor-alpha induced programmed cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Epidemiology of human immunodeficiency virus encephalopathy in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Neurodegeneration in Alzheimer disease. Is apoptosis involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Histochemical detection of apoptosis in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Glial cytokines in Alzheimer's disease: review and pathogenic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Antioxidant treatment with phenyl-alpha-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Neurologic manifestations of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Studies of neuroimmune markers in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Evidence for apoptotic cell death in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Chronic antioxidant treatment improves the cognitive performance of aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Cytokine expression in the brain during the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Tumor necrosis factor-alpha induces p53-dependent apoptosis in rat glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900351-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(98)00351-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9622673%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference